Play Video

Improving outcomes and combating AMR by giving the best drug every time

iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market.

We have a test delivering results in 3-4 hours from a positive blood bottle or a raw urine sample, saving lives and reducing the spread of antimicrobial resistance.

iFAST selected for the Healthcare Innovation Consortium's AMR Innovation Programme

We are delighted to have been selected to join five other companies looking to address antimicrobial resistance and will receive support to commercialise and scale our work.

The Problem

Bacteria are increasingly resistant to antibiotics – resistance levels are 20% - 98% and unpredictable. Current Antimicrobial Susceptibility Testing (AST) takes 48 -72 hours – patients deteriorate whilst waiting for the correct drug.

Prescribing inappropriate antibiotics leads to the spread of resistant infections, sepsis and death Antimicrobial resistance (AMR) caused over 1 million deaths in 2019 – more than malaria or AIDS.

iFAST reduces AST test time from 48+ to 3 hours

Blood/urine sample Incubated

Bacteria is extracted from a raw sample and then exposed to a range of antibiotics.

Test itself takes
30 seconds

Following a two hour incubation, reader scans 5000 individual bacteria.

RESISTANT/
SUSCEPTIBLE Output

iFAST reader determines
optimum antibiotic for clinician to prescribe

iFAST helps to solve the problem

Time to Result

Results in under 3 hours (blood) and 4 hours (raw urine sample)

High throughput

Each reader performs
> 25 tests/day

Cost

£20 per patient,
cheaper than current
gold standard methods

The data you need

Resistant/Susceptible and Minimum
Inhibitory Concentration (MIC)
for up to 15 drugs per sample

Research systems available NOW with UK regulatory approval expected by the end of 2024

Each sample analysed in less than a minute

The electrical properties of single bacteria are measured at high speed in a microfluidic chip.

Experienced and committed team

Dr Toby King

CEO

Prof Hywel Morgan

CTO

Dr Dan Spencer

VP Engineering

Prof Mark Sutton

Advisory Board Chair

To find out more

If you would like find out more please send us
an email and we will get in touch.

Find our presentation, nature paper below & synopsis for hospitals below.

Latest News

Bacteria zapped in a fight with antibiotic resistance.

New spinout from University of Southampton is seeking to help solve one of the biggest threats to world health: antibiotic resistance

Spectacular results
with our first two hospital evaluations!

We are thrilled with the outcome of our first two hospital evaluations with our iFAST demonstrator platform - the results are spectacular! Both trials were comparing the iFAST technology with the hospital current standard of care (disk diffusion), using patient blood samples.

Latest Videos

Play Video

Watch iFAST video - 3.5 mins

Play Video

Watch iFAST video - 49 secs

Upcoming Events

Monday 22 April 2024

Wimpole Street, London W1G 0AE

Delighted that iFast has been selected to pitch to investors at the Rare Founders Demo Day and Conference.

9am-5pm (conference)
6pm to 9pm (networking drinks)

For more information please visit Rare Founders Demo Day.

Barcelona, Spain – April 27 – 30, 2024

34th European Congress of Clinical Microbiology & Infectious Diseases

iFAST are exhibiting at

Stand F52

For more information please visit ECCMID.

Sign up to our Newsletter

Get in Touch

+44 (0)7788 595176

toby@ifastdiagnostics.com

iFAST Diagnostics, Building 85, University Road, Southampton, Hampshire SO17 1BJ, United Kingdom

FOLLOW US:

© 2024 All rights Reserved. Design by Caramel Design

iFAST Diagnostics, Building 85, University Road, Southampton, Hampshire SO17 1BJ, United Kingdom

Scroll to Top